Andrew Beaser to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Andrew Beaser has written about Anti-Arrhythmia Agents.
Connection Strength
0.209
-
A large deletion in RYR2 exon 3 is associated with nadolol and flecainide refractory catecholaminergic polymorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2019 08; 42(8):1146-1154.
Score: 0.168
-
Impact of Atrial Fibrillation Ablation onĀ Recurrent Hospitalization: A Nationwide Cohort Study. JACC Clin Electrophysiol. 2019 03; 5(3):330-339.
Score: 0.041